Inve India ▾

Zydus Wellness share price & results

Zydus Wellness Limited· Fast Moving Consumer Goods

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Ahmedabad-based FMCG maker of Sugar Free, Complan, Nycil, Everyuth, Nutralite & RiteBite Max Protein brands

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue1,437 ₹ crore+66.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin17.0 %−1.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit119 ₹ crore−7.0% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity3.84 %−2.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin3.16 %−8.5 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)66.25 %+29.9 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

1 of 2 judged targets kept · 9 open · verdicts reflect calls analysed to Q1 FY27.

Zydus Wellness Limited management guidance track record on Inve: 11 targets tracked across analysed earnings calls (1 achieved, 1 missed, 9 open).

TargetOriginal wordingSaidLatest callVerdict
Comfort Click EPS AccretionThe acquisition of Comfort Click is cash EPS accretive.
Call transcript, Q2 FY26 · 5 Nov 2025		Q2 FY26Q1 FY27:Promise remains achieved. Management confirmed Comfort Click continued to be EPS accretive in Q1 FY27.
Call transcript, Q1 FY27 · 4 Aug 2026		Achieved
Cash Tax Payout / Tax RateFY '26 and FY '27, there won't be any cash tax payout.
Call transcript, Q4 FY25 · 23 May 2025		Q4 FY25Q1 FY27:Promise remains missed. Management confirmed for FY27, 12-15% of the total ~25% tax rate will be a cash component, directly contradicting the original 'no cash tax payout' promise.
Call transcript, Q1 FY27 · 4 Aug 2026		Missed
Seasonal Brands Growthover three to four years, I think should be able to give us a good double-digit growth
Call transcript, Q4 FY26 · 18 May 2026		Q4 FY26Q1 FY27:Seasonal brands declined by 12% in Q1 FY27 due to unseasonal rains, putting the long-term double-digit growth target at risk. Management noted early signs of recovery post-quarter.
Call transcript, Q1 FY27 · 4 Aug 2026		At Risk

Source: Inve Guidance Tracker for Zydus Wellness Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Zydus Wellness Limited's 11 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 8 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹474.1 +2.32% · +₹10.75

Last close 26 Oct 2026 · NSE · INR · Source: Inve

Performance −2.2% 1Y

₹400₹450₹500₹550₹600Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 4 Nov 2025Q3 FY26 — 3 Feb 2026Q4 FY26 — 18 May 2026Q1 FY27 — 4 Aug 2026

1Y: ₹484.9 on 24 Oct 2025 → ₹474.1. High ₹602.5 (20 Jul 2026), low ₹373.5 (9 Mar 2026).

Previous close
₹463.35
Market cap
₹15.1k Cr
52-week range
₹373.5 – ₹602.5
One year
−3.14%
Price to earnings (TTM to Jun 2026)
68.25×
Return on equity (TTM to Jun 2026)
3.84%

Overview

Symbol
NSE:ZYDUSWELL
Exchange
NSE
Currency
INR

What Zydus Wellness Limited does

Based on the company's own presentations, annual report and earnings calls.

Zydus Wellness Limited manufactures and markets a portfolio of health, nutrition and personal-care brands across two core segments, Food & Nutrition and Personal Care, earning through sale of packaged consumer products via general trade, modern trade, e-commerce and quick-commerce channels in India and overseas. Its own production is backed by third-party (3P) manufacturers in India and abroad, and it has grown through acquisitions such as Heinz India (Complan, Glucon-D, Nycil), Carnation Nutra Science (RiteBite Max Protein) and, internationally, Comfort Click/Alidac UK (WeightWorld, Animigo, maxmedix). The company sources agricultural inputs such as milk directly and indirectly from a farmer network and distributes products through a multi-tier network of distributors, wholesalers and direct retail outreach.

Segments

  • Food & Nutrition
  • Personal Care
Manufacturing facilities in India
4
Third-party (3P) contract manufacturers
23 (3 international + 20 domestic)
Employees
1,500+
Distributors
1,950+
Retail stores reached
~2.8 million
Feet-on-street sales representatives
2,700+
Founded 1994Headquarters Ahmedabad, Gujarat, India Company website

How the price took the results

close before → close after

Q1 FY27
−1.7%
4 Aug
Q4 FY26
−1.3%
18 May
Q3 FY26
−3.7%
3 Feb
Q2 FY26
−4.1%
5 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Zydus Wellness Limited

Free account: one company. Everything above stays public.

Write why you follow Zydus Wellness Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Fast Moving Consumer Goods companies

All Fast Moving Consumer Goods companies → · Fast Moving Consumer Goods earnings growth →

Learn to analyse Zydus Wellness Limited

Guides on how to read this kind of business and the numbers that matter.